ID   K7 [Human thyroid carcinoma]
AC   CVCL_6307
DR   Cosmic; 1789445
DR   Wikidata; Q54899427
RX   PubMed=9054892;
RX   PubMed=10646882;
CC   Doubling time: 22 hours (PubMed=9054892).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=9054892; DOI=10.1016/S0360-3016(96)00449-X;
RA   Challeton de Vathaire, Cecile
RA   Branea, Felicia
RA   Schlumberger, Martin
RA   Gaillard, Nadine
RA   de Vathaire, Florent
RA   Badie, Christophe
RA   Antonini, Patrick
RA   Parmentier, Claude
RT   "Characterization and radiosensitivity at high or low dose rate of
RT   four cell lines derived from human thyroid tumors.";
RL   Int. J. Radiat. Oncol. Biol. Phys. 37:163-169(1997).
//
RX   PubMed=10646882; DOI=10.1054/bjoc.1999.0920; PMCID=PMC2363282;
RA   Bounacer, Ali
RA   Schlumberger, Martin
RA   Wicker, Rene
RA   du Villard, Jean-Antoine
RA   Caillou, Bernard
RA   Sarasin, Alain
RA   Suarez, Horacio Guillermo
RT   "Search for NTRK1 proto-oncogene rearrangements in human thyroid
RT   tumours originated after therapeutic radiation.";
RL   Br. J. Cancer 82:308-314(2000).
//